ACIST CVi ACIST® Medical Systems, a Bracco Group company, develops advanced contrast injection technologies that help simplify the complexities of the cardiac cath lab.

ACIST RXi The ACIST RXi is the only Rapid Exchange FFR System and helps to simplify physiological assessment of complex coronary artery disease.

ACIST HDi The first high definition IVUS system is now indicated for both coronary and peripheral vasculature procedures.

The Bracco Fellowships are back 95 grants to celebrate Bracco’s 95th Anniversary

BIPSO further strengthens environmental protection BIPSO sets the course for sterile contrast media production according to the latest environmental standards.

FDA approves Gadopiclenol injection for the U.S. market Bracco Announces FDA Approval of Gadopiclenol Injection, a New Macrocyclic High-Relaxivity Gadolinium-Based Contrast Agent which will be commercialized as VUEWAY™ (gadopiclenol) injection and VUEWAY™ (gadopiclenol) Pharmacy Bulk Package by Bracco.

Iomeron 400 Iomeron® is a tri-iodinated non-ionic monomeric contrast medium for radiology

Contrast Induced Nephropathy Contrast Induced Nephropathy

Data protection Data Protection

Cookie Policy Cookie Policy